Full Professor(heuristic)

Estrogen and related hormone effects · Genetics

Compare more Genetics professors.

h-index45
i10-index73
Publications309
Citations15,724

Grants

9 total · 2 active

NIH #P01CA278735

Advancing Hormone Therapy for Endometrial Cancer

Active
Amount
$2M–$3M
Period
2025-08-08 → 2030-07-31
PIs
2

Awarded at UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR

NIH #R01CA289731

The combined role of ARID1A loss and estrogen signaling in endometrial cancer

Active
Amount
$400K–$500K
Period
2024-03-04 → 2029-02-28
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R21CA270580

Mechanisms of tamoxifen-associated endometrial cancer risk

Amount
$200K–$300K
Period
2023-05-01 → 2025-04-30
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

9 total · 2 active

NIH #P01CA278735

Advancing Hormone Therapy for Endometrial Cancer

Active
Amount
$2M–$3M
Period
2025-08-08 → 2030-07-31
PIs
2

Awarded at UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR

NIH #R01CA289731

The combined role of ARID1A loss and estrogen signaling in endometrial cancer

Active
Amount
$400K–$500K
Period
2024-03-04 → 2029-02-28
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R21CA270580

Mechanisms of tamoxifen-associated endometrial cancer risk

Amount
$200K–$300K
Period
2023-05-01 → 2025-04-30
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #P30CA042014

Nuclear Control of Cell Growth and Differentiation (NC)

Amount
<$100K
Period
1997-05-09 → 2025-04-30
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R21AG067350

In vivo multiplexed silencing of cis-elements in the brain

Amount
$400K–$500K
Period
2021-05-01 → 2024-04-30
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R01HG008974

In situ evaluation of combinatorial gene regulation in the human genome

Amount
$600K–$700K
Period
2017-07-01 → 2022-04-30
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R21CA196455

Development of Enhancer RNA-based Biomarkers in FFPE Tissue

Amount
$200K–$300K
Period
2015-09-01 → 2018-08-31
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #R00HG006922

Impact of enhancer sequence and interacting factors on estrogen receptor-mediated

Amount
$200K–$300K
Period
2012-07-18 → 2017-11-30
PIs
1

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #K99HG006922

Impact of enhancer sequence and interacting factors on estrogen receptor-mediated

Amount
<$100K
Period
2012-07-18 → 2014-04-30
PIs
1

Awarded at HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY

Recent Public Signals

  1. New preprint: Identification of genomic features that uniquely impact estrogen receptor alpha binding and its effects on gene expression in endometrial cancer2025-12-15
  2. New paper: Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer. (UNC Libraries)2025-12-09
  3. New NIH award: Advancing Hormone Therapy for Endometrial Cancer2025-08-08

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-7568-6789

Professor Insights

Career Trajectory